In vivo Evaluation of Cenderitide-Eluting Stent (CES) II
In vivo Evaluation of Cenderitide-Eluting Stent (CES) II
About this item
Full title
Author / Creator
Publisher
New York: Springer US
Journal title
Language
English
Formats
Publication information
Publisher
New York: Springer US
Subjects
More information
Scope and Contents
Contents
The use of drug-eluting coronary stents has led to significant reduction in
in
-
stent
restenosis (ISR), but led to delayed endothelialization, necessitating the prolonged use of expensive anti-thrombotic drugs with their side-effects. Cenderitide (CD-NP) is a novel anti-proliferative chimeric peptide of semi-endothelial origin. Our pre...
Alternative Titles
Full title
In vivo Evaluation of Cenderitide-Eluting Stent (CES) II
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4715776
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_4715776
Other Identifiers
ISSN
0090-6964
E-ISSN
1573-9686
DOI
10.1007/s10439-015-1389-1
